Ropinirole adjunct to methylphenidate versus placebo adjunct to methylphenidate for attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled trial.
- DOI
- 10.1007/s00787-026-03171-8
- Published
- 2026 Aug 25
- Container
- European child & adolescent psychiatry
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00787-026-03171-8,
title = {Ropinirole adjunct to methylphenidate versus placebo adjunct to methylphenidate for attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled trial.},
author = {Farahvash A and Naseh E and Morovvati M and Shamabadi A and Fard MM and Zamani Z and Mobini B and Akhondzadeh S},
year = {2026},
journal = {European child \& adolescent psychiatry},
doi = {10.1007/s00787-026-03171-8},
url = {https://doi.org/10.1007/s00787-026-03171-8}
}RIS
TY - JOUR TI - Ropinirole adjunct to methylphenidate versus placebo adjunct to methylphenidate for attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled trial. AU - Farahvash A AU - Naseh E AU - Morovvati M AU - Shamabadi A AU - Fard MM AU - Zamani Z AU - Mobini B AU - Akhondzadeh S PY - 2026 JO - European child & adolescent psychiatry DO - 10.1007/s00787-026-03171-8 UR - https://doi.org/10.1007/s00787-026-03171-8 ER -
APA
A, F., E, N., M, M., A, S., MM, F., Z, Z., B, M., & S, A. (2026). Ropinirole adjunct to methylphenidate versus placebo adjunct to methylphenidate for attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled trial.. European child & adolescent psychiatry. https://doi.org/10.1007/s00787-026-03171-8
Source records
- pubmed · retrieved 2026-09-27T09:41:35.730Z